O A Lapchinskaya,G S Katrukha,L P Terekhova et al.
O A Lapchinskaya et al.
The strain Streptomyces roseoflavus INA-1278 is described as a new irumamicin producer. Irumamicin 1278 is different by the antifungal activity from irumamicin produced by the world-known strain Streptomyces subflavus subsp. Irumaensis subp...
[Secondary Metabolites from Marine Microorganisms. I. Secondary Metabolites from Marine Actinomycetes] [0.03%]
海洋放线菌次生元代谢产物的研究(I)
T I Orlova,V G Bulgakova,A N Polin
T I Orlova
Review represents data on new active metabolites isolated from marine actinomycetes published in 2007 to 2014. Marine actinomycetes are an unlimited source of novel secondary metabolites with various biological activities. Among them there ...
A S Trenin
A S Trenin
Due to extensive distribution of pathogen resistance to available pharmaceuticals and serious problems in the treatment of various infections and tumor diseases, the necessity of new antibiotics is urgent. The basic methodological approache...
O N Sineva,L P Terekhova
O N Sineva
Many diverse methods for selective isolation of actinomycetes are used in discovery of organisms producing biologically active substances, as well as in ecological studies. Methods for isolation of rare actinomycetes from soil are reviewed.
[Pharmacoeconomic Analysis of the Use of Hepatoprotectors in Management of Drug-Associated Liver Injury Due to Hodgkin's Lymphoma Chemotherapy] [0.03%]
药物性肝损伤的成本效益分析：霍奇金淋巴瘤化疗所致肝脏保护剂使用探讨
D D Morikov,E G Morikova,V V Dvornichenko
D D Morikov
The data on the pharmacoeconomic research of the use of Remaxol in treatment of drug-associated liver injury due to the chemotherapy in cancer patients are presented. The costs-efficiency method was applied to two groups of the patients wit...
[Immunomodulator Intensification of Etioropic Therapy in Patients with Advanced Pulmonary Tuberculosis] [0.03%]
免疫调节剂强化原发病素治疗对晚期肺结核患者的疗效观察
V M Kolomiets,A V Abramov,N V Rachina et al.
V M Kolomiets et al.
The study was aimed at possible increase of the therapy efficacy in patients with advanced tuberculosis by including immunomodulators to the treatment schemes. The data concerning 6034 patients with advanced tuberculosis, mainly fibrocavern...
Randomized Controlled Trial
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 2015;60(7-8):18-22. DOI: 2015
[Assessment of Antitumor Effect of Submerged Culture of Ophiocordyceps sinensis and Cordyceps militaris] [0.03%]
冬虫夏草和北虫草固体发酵的抗肿瘤作用评估
A V Avtonomova,L M Krasnopolskaya,M I Shuktueva et al.
A V Avtonomova et al.
Ophiocordyceps sinensis and Cordyceps militaris metabolites showed a high potential in the treatment of tumors as well as some other diseases. Antitumor properties of O. sinensis and C. militaris submerged mycelium were investigated. It was...
[Investigation of Therapeutic Efficacy of Triazavirin Against Experimental Forest-Spring Encephalitis on Albino Mice] [0.03%]
三氮唑核苷治疗远东邦型脑炎实验性感染的疗效研究
S Ya Loginova,S V Borisevich,V L Rusinov et al.
S Ya Loginova et al.
The comparative study of the therapeutic efficacy of Triazavirin against experimental Forest-Spring encephalitis on albino mice vs. the active drug Ribavirin® showed that in high doses (200-400 mg/kg) Triazavirin moderately protected the i...
Comparative Study
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 2015;60(7-8):11-3. DOI: 2015
[Structural Polymorphism of Genome Islands Encoding Resistance to Beta-Lactams in Coagulase-Negative Staphylococci Isolated at Hospitals of the Russian Federation] [0.03%]
俄罗斯医院分离的耐β-内酰胺基因岛在凝固酶阴性的葡萄球菌中的结构多态性
O A Dmitrenko,A S Ankirskaya,L A Lyubasovskaya et al.
O A Dmitrenko et al.
Coagulase-negative staphylococci (CoNS) are considered as a reservoir of mobile genetic elements and first of all of the staphylococcal cassette chromosome mec (SCCmec), defining staphylococci resistance to beta-lactams. Types II, IV, IVa, ...
[Up-to-Date Aspects of Antihypertensive Therapy from the Viewpoint of Cardio- and Nephroprotective Action: Olmesartan] [0.03%]
从心肾保护角度展望高血压治疗的新近进展-奥美沙坦的作用机制和临床价值
A G Evdokimova,Yu V Ryzhova
A G Evdokimova
The literature data on possible optimization of the arterial hypertension management with organoprotective antihypertensive agents are reviewed. Omesartan is one of the most thoroughly investigated agents blocking the receptors to angiotens...